Trials / Completed
CompletedNCT02460692
Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain
A Randomized Controlled Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 131 (actual)
- Sponsor
- University of California, San Diego · Academic / Other
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will involve treating low back pain associated with nerve injury with oral delta-9-tetrahydrocannabinol (Δ9-THC) or whole plant cannabis for eight weeks. Research subjects will consume either oral Δ9-THC (dronabinol), vaporized 3.7% Δ9-THC/5.6% CBD, or placebo. An analysis will then be determined to assess the risk--benefit ratio of dronabinol and vaporized 3.7% Δ9-THC/5.6% CBD .
Detailed description
The present study is designed to assess whether treatment with vaporized cannabis or dronabinol (oral Δ9-THC) reduces spontaneous and evoked pain more than placebo, and whether there are any differences between the two active treatments in terms of interference with activities of daily living. This study also aims to examine the effects of vaporized whole plant cannabis and dronabinol on mood, neuropsychological function, and psychomimetic side-effects (high, stoned, etc.) compared to placebo and to each other. In addition, we plan to examine the acute effects (after receiving stable treatment for 4 weeks) of vaporized cannabis and dronabinol compared to placebo and each other on driving skills.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebos | Administration of vaporized cannabis plus either dronabinol or placebo pill |
| DRUG | dronabinol | Administration of vaporized cannabis plus either dronabinol or placebo pill |
| DRUG | Vaporized Cannabis 3.7% THC/5.6% CBD | Administration of vaporized cannabis plus either dronabinol or placebo pill |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2020-03-25
- Completion
- 2020-03-25
- First posted
- 2015-06-02
- Last updated
- 2023-09-28
- Results posted
- 2023-09-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02460692. Inclusion in this directory is not an endorsement.